OTCMKTS:HKMPF Hikma Pharmaceuticals (HKMPF) Stock Price, News & Analysis $21.10 -1.09 (-4.90%) As of 03:01 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendNews and TrendsShort Interest About Hikma Pharmaceuticals Stock (OTCMKTS:HKMPF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Hikma Pharmaceuticals alerts:Sign Up Key Stats Today's Range$21.10▼$21.1150-Day Range$20.37▼$22.2852-Week Range$16.34▼$25.34Volume22,673 shsAverage Volume1,605 shsMarket Capitalization$4.68 billionP/E RatioN/ADividend Yield3.60%Price TargetN/AConsensus RatingModerate Buy Company Overview Hikma Pharmaceuticals plc is a multinational pharmaceutical company that develops, manufactures and markets a broad portfolio of medicines. Its products include generic and specialty pharmaceuticals, injectable medicines, and branded treatments across a range of therapeutic areas. The company operates through three principal businesses: Injectables, which supplies hospital and clinical medicines; Generics, which offers off-patent prescription products, primarily in the United States; and Branded, which markets medicines under established brand names across the Middle East and North Africa. Hikma also provides contract manufacturing and other pharmaceutical services in selected markets. Founded in Jordan in 1978 by Samih Darwazah, Hikma has expanded into an international pharmaceutical group serving patients and healthcare providers in the United States, Europe, the Middle East and North Africa, and other markets. The company is headquartered in London, with manufacturing, research and commercial operations in multiple countries.AI Generated. May Contain Errors. Read More Receive HKMPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HKMPF Stock News HeadlinesHikma Pharmaceuticals (OTCMKTS:HKMPF) Upgraded at BarclaysSeptember 11, 2026 | americanbankingnews.comHikma updates market on total voting rights and share capitalSeptember 1, 2026 | tipranks.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.September 21 at 1:00 AM | InvestorPlace (Ad)Hikma completes $250m share buyback, reshaping capital structureAugust 28, 2026 | tipranks.comHikma Executives Restructure Pledges Over 2 Million Shares via DarholdAugust 24, 2026 | tipranks.comHikma Advances $250m Share Buyback, Tightens Free FloatAugust 24, 2026 | tipranks.comHikma Pharmaceuticals Balances Strong H1 With Cautious OutlookAugust 23, 2026 | theglobeandmail.comHikma steps up $250m buyback with latest share repurchasesAugust 17, 2026 | tipranks.comSee More Headlines HKMPF Stock Analysis - Frequently Asked Questions How have HKMPF shares performed this year? Hikma Pharmaceuticals' stock was trading at $20.94 on January 1st, 2026. Since then, HKMPF shares have increased by 0.8% and is now trading at $21.10. How do I buy shares of Hikma Pharmaceuticals? Shares of HKMPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/21/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:HKMPF Previous SymbolOTC:HKMPF CIKN/A Webwww.hikma.com Phone442073992760Fax44-20-7399-2761Employees9,400Year Founded1978Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.57 Current Ratio1.82 Quick Ratio1.06 Sales & Book Value Annual Sales$3.35 billion Price / Sales1.40 Cash Flow$3.18 per share Price / Cash Flow6.64 Book Value$11.74 per share Price / Book1.80Miscellaneous Outstanding Shares221,890,000Free FloatN/AMarket Cap$4.68 billion OptionableNot Optionable Beta0.61 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:HKMPF) was last updated on 9/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HKMPF Stock Alerts